Abstract:A 28-year-old woman with thyroid hemiagenesis, who had been diagnosed as having Graves' disease, became pregnant during the course of methimazole treatment. The treatment was terminated in the second trimester. She delivered a normal infant at full term. She became thyrotoxic 3 months after the delivery, hypothyroid 6 months after the delivery, and finally euthyroid 11 months after the delivery without undergoing any treatment. This clinical course indicates that she developed silent thyroiditis after the deli… Show more
“…Most observed cases of thyroid hemiagenesis have been found only incidentally after patients have been examined for thyroid conditions since the absence of one thyroid lobe usually does not cause clinical symptoms by itself [2][3][4][5][6][7][8][9]. There has been only one survey to establish its prevalence among patients with thyroid disorders [2].…”
Section: Discussionmentioning
confidence: 99%
“…There has been only one survey to establish its prevalence among patients with thyroid disorders [2]. Since thyroid hemiagenesis is very rare entity, many case reports have been published describing the association with other thyroid diseases or congenital defects, mostly cardiac [2][3][4][5][6][7][8][9]. The associated diseases in the intact thyroid lobe include benign adenoma, multinodular goiter, hyperthyroidism, chronic thyroiditis, Graves' disease, and rarely carcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…Since thyroid hemiagenesis is a rare entity, many case reports have been published describing the association with other thyroid diseases or congenital defects [2][3][4][5][6][7][8][9]. The increased prevalence of thyroid diseases in association with thyroid hemiagenesis and observed female preponderance have been questioned after surveys, investigating the true prevalence of thyroid hemiagenesis in normal population [10][11][12].…”
Thyroid hemiagenesis is a rare form of thyroid dysgenesis, in which one thyroid lobe fails to develop. The true prevalence of this rare abnormality is about 0.05-0.2% in normal population. We aimed to determine prevalence of thyroid hemiagenesis in patients with various thyroid disorders and a normal population in a mild to moderate iodine-deficient area. The clinical and thyroid ultrasonography records of 4,833 patients who presented with various thyroid disorders were reviewed. In addition, ultrasonographic data of two large surveys carried out for the community screening of iodine status of children (n = 4,772) and thyroid disorders of adult subjects (n = 2,935) were analyzed. In patients with thyroid disorders, we found 12 cases with thyroid hemiagenesis (0.25%). Thyroid hemiagenesis was due to the agenesis of the left lobe in all cases. The underlying thyroid diseases were Hashimoto's thyroiditis (n = 4), euthyroid multinodular goiter (n = 4), and toxic adenoma (n = 1). Three subjects have no underlying thyroid disease. In ultrasonography screening of normal population, altogether, the absence of the left lobe was detected in only two cases, indicating a true prevalence of thyroid hemiagenesis of 0.025%. None of the reviewed patients had thyroid dysfunction. Our community-based data is in accordance with previous studies in terms of prevalence and male-to-female ratio.
“…Most observed cases of thyroid hemiagenesis have been found only incidentally after patients have been examined for thyroid conditions since the absence of one thyroid lobe usually does not cause clinical symptoms by itself [2][3][4][5][6][7][8][9]. There has been only one survey to establish its prevalence among patients with thyroid disorders [2].…”
Section: Discussionmentioning
confidence: 99%
“…There has been only one survey to establish its prevalence among patients with thyroid disorders [2]. Since thyroid hemiagenesis is very rare entity, many case reports have been published describing the association with other thyroid diseases or congenital defects, mostly cardiac [2][3][4][5][6][7][8][9]. The associated diseases in the intact thyroid lobe include benign adenoma, multinodular goiter, hyperthyroidism, chronic thyroiditis, Graves' disease, and rarely carcinoma.…”
Section: Discussionmentioning
confidence: 99%
“…Since thyroid hemiagenesis is a rare entity, many case reports have been published describing the association with other thyroid diseases or congenital defects [2][3][4][5][6][7][8][9]. The increased prevalence of thyroid diseases in association with thyroid hemiagenesis and observed female preponderance have been questioned after surveys, investigating the true prevalence of thyroid hemiagenesis in normal population [10][11][12].…”
Thyroid hemiagenesis is a rare form of thyroid dysgenesis, in which one thyroid lobe fails to develop. The true prevalence of this rare abnormality is about 0.05-0.2% in normal population. We aimed to determine prevalence of thyroid hemiagenesis in patients with various thyroid disorders and a normal population in a mild to moderate iodine-deficient area. The clinical and thyroid ultrasonography records of 4,833 patients who presented with various thyroid disorders were reviewed. In addition, ultrasonographic data of two large surveys carried out for the community screening of iodine status of children (n = 4,772) and thyroid disorders of adult subjects (n = 2,935) were analyzed. In patients with thyroid disorders, we found 12 cases with thyroid hemiagenesis (0.25%). Thyroid hemiagenesis was due to the agenesis of the left lobe in all cases. The underlying thyroid diseases were Hashimoto's thyroiditis (n = 4), euthyroid multinodular goiter (n = 4), and toxic adenoma (n = 1). Three subjects have no underlying thyroid disease. In ultrasonography screening of normal population, altogether, the absence of the left lobe was detected in only two cases, indicating a true prevalence of thyroid hemiagenesis of 0.025%. None of the reviewed patients had thyroid dysfunction. Our community-based data is in accordance with previous studies in terms of prevalence and male-to-female ratio.
“…Shortly prior to becoming pregnant, an increase in thyroperoxidase autoantibodies (TPOAb) was observed in this woman. In another Japanese woman with thyroid hemiagenesis, GD was present in the pregnancy that preceded the postpartum period during which PPT appeared (45). Other case reports of PPT following GD have appeared in the literature (46, 47), one being noteworthy because of the sequence onset of GD → PPT → relapse of GD (47).…”
The year following parturition is a critical time for the de novo appearance or exacerbation of autoimmune diseases, including autoimmune thyroid disease. The vast majority of postpartum thyroid disease consists of postpartum thyroiditis (PPT) and the minority by Graves’ disease and non-autoimmune thyroiditis. PPT has a worldwide prevalence ranging from 1 to 22% and averaging 5% based on a review published in 2012. Several factors confer risk for the development of PPT. Typically, the clinical course of PPT is characterized by three phases: thyrotoxic, hypothyroid, and euthyroid phase. Approximately half of PPT women will have permanent hypothyroidism. The best humoral marker for predictivity, already during the first trimester of gestation, is considered positivity for thyroperoxidase autoantibodies (TPOAb), though only one-third to half of such TPOAb-positive pregnant women will develop PPT. Nutraceuticals (such as selenium) or omega-3-fatty acid supplements seem to have a role in prevention of PPT. In a recent study on pregnant women with stable dietary habits, we found that the fish consumers had lower rates of positivity (and lower serum levels) of both TPOAb and thyroglobulin Ab compared to meat eaters. Finally, we remind the reader of other diseases that can be observed in the postpartum period, either autoimmune or non-autoimmune, thyroid or non-thyroid.
“…However, the etiopathogenesis of this condition, its clinical significance, impact on thyroid function, and development of associated thyroid pathologies as well as the management of patients in whom the anomaly is diagnosed are still a matter of debate (1,(4)(5)(6)(7). To date, individual case studies have been reported most often, mainly as an anatomical curiosity or as a diagnostic dilemma, whereas the literature lacks methodological studies of large groups of patients presenting THA, which would provide objective answers to these controversies (4,5,(8)(9)(10)(11)(12)(13). Since hormone production by a single thyroid lobe is sufficient to maintain clinical euthyroidism, provided no concomitant thyroid pathology exists, THA has been up to now regarded as a rather benign developmental variant requiring no treatment.…”
Objective: Thyroid hemiagenesis (THA) is an anomaly resulting from the developmental failure of one thyroid lobe. Etiopathogenesis, clinical significance, and management of patients in whom THA is diagnosed are still a matter of debate. The aim of the study is to provide the first systematic analysis of a large cohort of subjects with THA. Design: Forty patients with THA are described in comparison to a control group of 80 subjects with fully developed thyroid gland. Methods: Serum concentrations of thyrotropin (TSH), free thyroxine (FT 4 ), free triiodothyronine (FT 3 ), and thyroid autoantibodies were measured. In 37 patients, thyroid ultrasonography and Tc-99m thyroid scintiscan were performed, followed by fine-needle aspiration biopsy if indicated. The remaining archival three cases were diagnosed with the use of I-131 scintiscan under basal conditions and after TSH stimulation. Results: Patients with THA, while usually clinically euthyroid, presented with significantly higher levels of TSH and FT 3 as well as with higher FT 3 /FT 4 concentration in comparison to the control group. Furthermore, a higher incidence of associated functional, morphological, and autoimmune thyroid disorders in patients with THA was observed when compared to subjects with bilobate thyroid (P!0.05). Conclusions: Our results revealed that individuals with THA are more likely to develop thyroid pathology. The observed high incidence of associated pathologies is presumably due to long-lasting TSH overstimulation. Therefore, THA diagnosis should be followed by systematic observation and adequate levothyroxine treatment in patients with elevated TSH level.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.